Lifestance Health Group Inc (LFST)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $5.35B
Last updated: Nov 17, 2026 at 11:06 AM ET
Lifestance Health Group Inc (LFST) Financials: Revenue, Profit and Cash Flow
Lifestance Health Group reported revenue of $1.42B for the fiscal year ended Dec 31, 2025, up 13.9% from the year before. That year, net income was $9.66M with a net margin of 0.7%, operating cash flow was $146.15M and free cash flow was $110.03M. The quarter ended Sep 30, 2026 had revenue of $455.86M and net income of $22.39M.
Revenue and Margins
The operating margin was 1.7% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $212.52M, a compound annual rate of 37.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.42B | +13.9% | 100.0% | 1.7% | 0.7% |
| Dec 2024 | $1.25B | +18.5% | 100.0% | -2.5% | -4.6% |
| Dec 2023 | $1.06B | +22.8% | 100.0% | -17.9% | -17.6% |
| Dec 2022 | $859.54M | +28.8% | 100.0% | -24.5% | -25.1% |
| Dec 2021 | $667.51M | +77.0% | 100.0% | -42.9% | -46.0% |
| Dec 2020 | $377.22M | +77.5% | 35.6% | 4.1% | -10.1% |
| Dec 2019 | $212.52M | N/A | 100.0% | 7.2% | 2.7% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 1973.1% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.42B | $1.25B | $1.06B | $859.54M | $667.51M | $377.22M | $212.52M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $242.90M | $0 |
| Gross profit | $1.42B | $1.25B | $1.06B | $859.54M | $667.51M | $134.32M | $212.52M |
| Operating income | $24.15M | -$31.61M | -$189.13M | -$210.17M | -$286.35M | $15.44M | $15.24M |
| Net income | $9.66M | -$57.44M | -$186.26M | -$215.56M | -$307.20M | -$38.07M | $5.67M |
| EBITDA | $79.80M | $41.54M | -$102.83M | -$141.66M | -$238.26M | N/A | $20.09M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $455.86M | $435.35M | $403.48M | $382.19M | $363.81M | $345.31M | $332.97M | $325.48M | $312.72M | $312.33M | $300.44M | $280.60M |
| Gross profit | $455.86M | $435.35M | $403.48M | $382.19M | $363.81M | $345.31M | $332.97M | $325.48M | $312.72M | $312.33M | $300.44M | $280.60M |
| Operating income | $33.08M | $30.65M | $22.28M | $18.08M | $7.41M | -$2.95M | $1.60M | $1.06M | $47.00K | -$15.95M | -$16.77M | -$32.27M |
| Net income | $22.39M | $23.61M | $14.24M | $11.67M | $1.08M | -$3.79M | $709.00K | -$7.11M | -$5.96M | -$23.28M | -$21.10M | -$44.96M |
Balance Sheet
As of Dec 2025, total debt of $311.47M exceeded cash and equivalents by $62.83M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Total assets | $2.20B | $2.12B | $2.11B | $2.17B | $1.93B | $1.57B | $280.78M |
| Current assets | $416.20M | $312.51M | $225.73M | $233.22M | $266.52M | $76.28M | $27.43M |
| Cash and equivalents | $248.64M | $154.57M | $78.82M | $108.62M | $148.03M | $18.83M | $3.48M |
| Total liabilities | $682.92M | $672.01M | $681.04M | $655.15M | $382.08M | $536.89M | $447.13M |
| Short-term debt | $45.54M | $0 | $8.17M | $15.88M | $14.12M | $10.56M | $844.00K |
| Long-term debt | $265.93M | $279.79M | $280.29M | $225.08M | $157.42M | $362.53M | $79.31M |
| Shareholder equity | $1.52B | $1.45B | $1.43B | $1.52B | $1.55B | $997.84M | -$166.35M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.19B | $2.18B | $2.15B | $2.20B | $2.15B | $2.15B | $2.10B | $2.12B | $2.11B | $2.12B | $2.11B | $2.11B |
| Total liabilities | $693.89M | $704.35M | $668.47M | $682.92M | $656.23M | $672.88M | $647.57M | $672.01M | $670.85M | $689.32M | $677.32M | $681.04M |
| Cash and equivalents | $218.82M | $225.94M | $194.80M | $248.64M | $203.90M | $188.93M | $134.34M | $154.57M | $102.61M | $86.97M | $49.45M | $78.82M |
| Shareholder equity | $1.49B | $1.48B | $1.48B | $1.52B | $1.49B | $1.47B | $1.46B | $1.45B | $1.44B | $1.43B | $1.43B | $1.43B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 75.3% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $146.15M | $107.26M | -$16.88M | $52.79M | $9.42M | -$8.53M | $17.05M |
| Capital expenditures | $36.13M | $21.57M | $40.52M | $79.25M | $94.49M | $38.07M | $14.31M |
| Free cash flow | $110.03M | $85.69M | -$57.40M | -$26.47M | -$85.07M | -$46.60M | $2.73M |
| Investing cash flow | -$36.13M | -$21.57M | -$60.34M | -$139.46M | -$194.08M | -$861.17M | -$73.38M |
| Financing cash flow | -$15.96M | -$9.95M | $47.43M | $47.26M | $313.86M | $912.27M | $48.46M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $37.02M | $99.91M | $33.11M | $57.56M | $27.29M | $64.40M | -$3.09M | $62.32M | $22.72M | $44.06M | -$21.84M | $16.80M |
| Capital expenditures | $14.65M | $11.99M | $10.77M | $10.91M | $10.29M | $7.75M | $7.17M | $6.30M | $5.05M | $5.11M | $5.10M | $11.41M |
| Free cash flow | $22.36M | $87.92M | $22.34M | $46.65M | $17.00M | $56.64M | -$10.26M | $56.02M | $17.67M | $38.95M | -$26.94M | $5.38M |
Frequently Asked Questions About LFST
What is Lifestance Health Group's annual revenue?
Lifestance Health Group reported revenue of $1.42B for the fiscal year ended Dec 31, 2025.
How fast is Lifestance Health Group's revenue growing?
Revenue was up 13.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.3%.
Is Lifestance Health Group profitable?
Yes. Lifestance Health Group reported net income of $9.66M for the fiscal year ended Dec 31, 2025, with a net margin of 0.7%.
How much free cash flow does LFST generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $146.15M minus capital expenditures of $36.13M produced free cash flow of $110.03M.
How much debt does Lifestance Health Group have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $265.93M, short-term debt of $45.54M and cash and equivalents of $248.64M.
LFST pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors